Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM: US, France, Germany, Italy, Spain, ...

causing inflammation and reduced lung function. Urban dwellers face higher risks due to increased exposure from vehicles, ...

Emma Rubach, head of health advice at Asthma + Lung UK, said: "If the central heating is on and windows are closed, dust ...

Dupilumab, an injectable interleukin (IL)-4 and IL-13 pathway inhibitor, recently received FDA approval as the first-ever ...

Two posters presented at the CHEST 2024 annual meeting showed that mepolizumab significantly reduces exacerbations in ...

Low climate-impact corticosteroid inhalers are as effective as high climate impact inhalers for COPD and asthma outcomes, per ...

Depemokimab has already shown its potential as a therapy for severe asthma in two other phase 3 trials – SWIFT-1 and SWIFT-2 ...

Steroid tablets are associated with significant adverse side effects. Short-term use risks sleep disturbance, reflux, ...

The annual meeting of the American College of Chest Physicians was held this year from Oct. 6 to 9 in Boston, hosting participants from around the world, including specialists and heath care ...

Full session details can be accessed on the ACAAI website. The poster will be available on the publications page of the Apogee website on October 24.

The Asthma Society of Ireland has warned that over-use of steroid medication may cause more harm than good. A study has shown ...